Advertisements



Exelixis partner Ipsen announces EC approval of Cabometyx

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

Exelixis partner Ipsen announces EC approval of Cabometyx

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

Exelixis" Partner Ipsen Gets Approval for Cabometyx in Canada

Zacks.....»»

Category: topSource: redinewsSep 20th, 2018

Exelixis, Ipsen Receive Positive CHMP Opinion for Cabometyx

Exelixis, Inc. (EXEL) and partner Ipsen get a positive opinion from the CHMP for Cabometyx tablets as a monotherapy for the second-line treatment of hepatocellular carcinoma in adults. Exelixis, Inc......»»

Category: dealsSource: nytSep 24th, 2018

Exelixis says partner Daiichi Sankyo receives regulatory approval for MINNEBRO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2019

Exelixis Initiates Pivotal Liver Cancer Study on Cabometyx

Exelixis (EXEL) and its partner announce initiation of a pivotal study to evaluate its kidney cancer drug, Cabometyx, in combination with Roche's Tecentriq in liver cancer. Exelixis, Inc. EXEL along with its French partner, Ipse.....»»

Category: worldSource: nytDec 6th, 2018

Exelixis receives EC approval for Cabometyx tablets

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 15th, 2018

Exelixis, Ipsen Receive Positive CHMP Opinion for Cabometyx

Zacks.....»»

Category: topSource: redinewsSep 24th, 2018

Exelixis announces new recommendations for Cabometyx tablets in NCCN guidelines

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 7th, 2018

Exelixis announces FDA accepts sNDA for Cabometyx

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2018

Merck"s Partner Gets FDA Nod for Herceptin Biosimilar

Merck's (MRK) partner, Samsung Bioepis Co. gets FDA approval.....»»

Category: worldSource: nyt7 hr. 29 min. ago

Abbott announces FDA approval of TactiCath Contact Force Ablation Catheter

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 29 min. ago

Cellular Biomedicine announces AlloJoin approval for Phase 2 trial in China

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 17th, 2019

Adamis announces partner Sandoz"s U.S. launch of Symjepi

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 16th, 2019

NRG Energy announces LPSC approval of sale of South Central business

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 16th, 2019

Ironwood announces approval of LINZESS in China

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 15th, 2019

5 Reasons Why Investors Should Buy Exelixis (EXEL) in 2019

Exelixis (EXEL) lead drug, Cabometyx continues to perfo.....»»

Category: smallbizSource: nytJan 14th, 2019

Exelixis rises 5% after disclosing FDA approval of cabozantinib in carcinoma

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 14th, 2019

Exelixis stock up more than 4% after FDA drug approval

Shares of Exelixis Inc. rose more than 4% in the extended session Monday after the Alameda, Calif., biotech company said the U.S. Food and Drug Administration has approved its Cabometix drug for patients with certain types of advanced liver cancer.....»»

Category: topSource: marketwatchJan 14th, 2019

Abbott announces FDA approval of Amplatzer Piccolo Occluder

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 14th, 2019

FDA PDUFA Date for Exelixis for Cabometyx (Cabozantinib) is January 14, 2019

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 14th, 2019